MOTS EN ANGLAIS EN RAPPORT AVEC «AKATHISIA»
akathisia
barnes
scale
abilify
pronunciation
symptoms
treatment
tardive
ssri
akathisia
acathisia
syndrome
characterized
unpleasant
sensations
inner
restlessness
that
manifests
itself
with
inability
still
remain
motionless
medical
definitions
popular
movement
disorder
feeling
compelling
need
constant
motion
well
actions
such
dyskinesia
center
results
effect
using
aforementioned
likewise
result
managing
antipsychotic
induced
acute
chronic
miller
fleischhacker
frequent
common
adverse
spectrums
problem
history
concern
today
neurological
which
used
treat
various
psychiatric
disorders
physical
hiding
world
psychology
psych
central
wondering
really
just
sensation
shakiness
fidgeting
almost
like
your
whole
body
anxious
more
10 LIVRES EN ANGLAIS EN RAPPORT AVEC «AKATHISIA»
Découvrez l'usage de
akathisia dans la sélection bibliographique suivante. Des livres en rapport avec
akathisia et de courts extraits de ceux-ci pour replacer dans son contexte son utilisation littéraire.
1
Akathisia and Restless Legs
A comprehensive, scientific and clinical account of akathisia and related syndromes, including Restless Legs Syndrome.
2
Drug Injury: Liability, Analysis, and Prevention
Tardive akathisia refers to akathisia of delayed onset, in the absence of a recent
change in drug dose or type, or resulting from discontinuation of anti-akathisia
medications. It is associated with the emergence of symptoms for the first time
after ...
AKATHISIA AND RESTLESS LEGS SYNDROME No discussion of uncomfortable
symptoms in PD is complete without a mention of akathisia, or restlessness.
Restlessness is a frequent and potentially disabling complaint in PD.
Parkinsonian ...
Ronald F. Pfeiffer, Zbigniew K. Wszolek, Manuchair Ebadi, 2004
4
Encyclopedia of Movement Disorders, Three-Volume Set
Definition and History Akathisia is a disorder characterized by a subjective report
of inner restlessness with an inability to sit still, relieved by moving about. The
patient usually has repetitive movements, which involve primarily the legs and ...
5
A Guide to the Extrapyramidal Side-Effects of Antipsychotic ...
Akathisia decreases with antipsychotic dose reduction and remits with
antipsychotic withdrawal Subjective and objective restlessness not fulfilling
category 1 or 2, observed on only one occasion: qualified as'
concurrentantipsychotics'or Meets ...
D. G. Cunningham Owens, 2014
6
Manual of Clinical Psychopharmacology
Akathisia, the inner-driven restlessness caused by antipsychotics, is the least
understood and most troublesome of the neurological side effects of these agents
. It ranges from an unpleasant subjective feeling of muscular discomfort to an ...
Alan F. Schatzberg, Jonathan O. Cole, Charles DeBattista, 2010
7
Handbook of Essential Psychopharmacology, Second Edition
Q. Is akathisia an EPS in the sense that acute dystonic reactions and
parkinsonian symptoms are considered EPS? What is the best treatment for
akathisia? A. Akathisia is usually defined as motor restlessness accompanied by
an urge to ...
8
Drug-induced Dysfunction in Psychiatry
K. N. Roy Chengappa and Patrick Flynn At the turn of the century, Haskovec (
1901) described akathisia (Greek: a kathisia—the inability to remain seated) in a
patient with hysteria and in another with neurasthenia. Sicard (1923) noted the ...
Matcheri S. Keshavan, John S. Kennedy, 1992
9
Handbook of Drug Interactions: A Clinical and Forensic Guide
Because atypical antipsychotics do not frequently cause akathisia, many
presume that the dopamine-blocking qualities of traditional antipsychotics
account for this movement disorder. However, drugs that promote dopamine
transmission, ...
Ashraf Mozayani, Lionel Raymon, 2011
10
Handbook of Psychiatric Drug Therapy
Akathisia Clinical Presentation. Akathisia is experienced subjectively as an
intensely unpleasant sensation of restlessness and the need to move, especially
the legs. Patients often appear restless, with symptoms of anxiety, agitation, or
both.
Lawrence A. Labbate, Maurizio Fava, Jerrold F. Rosenbaum, 2012
10 ACTUALITÉS CONTENANT LE TERME «AKATHISIA»
Découvrez de quoi on parle dans les médias nationaux et internationaux et comment le terme
akathisia est employé dans le contexte des actualités suivantes.
Reducing antipsychotic dosage feasible, effective among patients …
... Barnes Rating Scale for Drug-Induced Akathisia (P = .03) and Udvalg for Kliniske Undersøgelser Side Effect Rating Scale (P < .001) scores ... «Healio, juil 15»
FDA Extends Review of Resubmitted Atypical Antipsychotic
Cariprazine has been shown to increase the risk of akathisia and extrapyramidal disorder, but it has not been linked to weight gain, metabolic ... «Pharmacy Times, juin 15»
AOP Orphan Strengthens Core CNS Specialty Business with High …
The most frequent adverse events reported with Tetrabenazine include sedation/somnolence, fatigue, insomnia, depression, akathisia and ... «PipelineReview.com, juin 15»
Pre- Market News Review: Mobile TeleSystems OJSC (NYSE:MBT …
... the study also showed a favorable safety and tolerability profile, counting low rates of depression, somnolence, insomnia and akathisia. «wsnewspublishers, juin 15»
Negative Closings - Teva Pharmaceutical Industries (TEVA …
... the study also showed a favorable safety and tolerability profile, including low rates of depression, somnolence, insomnia and akathisia. «Techsonian, juin 15»
Teva drug shows promise in movement disorder
In the ARM-TD trial, the drug was associated with "low rates of depression, somnolence, insomnia and akathisia," according to the company. «PMLiVE, juin 15»
Teva Announces Positive Results on Tardive Dyskinesia Drug …
... somnolence, insomnia and akathisia. In addition, fewer patients consuming SD-809 than placebo experienced serious adverse events, while ... «Nasdaq, juin 15»
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Releases …
... somnolence, insomnia and akathisia. The news led stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) as the shares decreased ... «StreetWise Report, juin 15»
Maxim Weighs in on Healthcare Stocks: Teva Pharmaceutical …
SD-809 showed a favorable safety and tolerability profile with low rates of adverse events, such as depression, somnolence, akathisia/ ... «Smarter Analyst, juin 15»
Cookies on Pharmiweb.Com
... the study also showed a favorable safety and tolerability profile including low rates of depression somnolence insomnia and akathisia. «PharmiWeb.com, juin 15»
